A previous study demonstrated that HDAC1/2 bind to the fatty acid synthase promoter and induce deacetylation of H3K9 and H3K27 (Liu et al., 2018), suggesting that HDAC1 may participate in the progression of fatty liver disease. Here, HDAC1 is linked to fatty liver disease.